it's great news. progressing towards phase 3 trial. I am holding small position and waiting to participate to capital raise which is likely to happen after this news in a week or two as they need anywhere between $30-50 million to spend on the phase 3 trials
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007, page-11
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.5¢ |
Change
0.025(3.68%) |
Mkt cap ! $86.79M | |||
| Open | High | Low | Value | Volume |
| 69.0¢ | 70.5¢ | 68.0¢ | $29.68K | 43.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 67.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 72.5¢ | 18000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
69.0¢ |
Change
0.025 ( 0.73 %) |
||||
| Open | High | Low | Volume | ||
| 68.0¢ | 69.0¢ | 68.0¢ | 9512 | ||
| Last updated 15.37pm 14/06/2024 ? | |||||
| AGN (ASX) Chart |